Morepen Laboratories Share Price Target 2025 – 2036 (Long Term)

Morepen Laboratories Limited, NSE: MOREPENLAB, BSE BOM: 500288, Share Price Target, Stock Price Targets, Future Prediction, Prognosis, Forecast 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2032, 2035, 2036

In this post, you can check the prediction of Morepen Laboratories share price target from the present time to the next 10 to 15 years, which will give you some idea about the level to which Morepen Laboratories share price has the potential to reach in the coming years. A custom algorithm has been used for these price targets or predictions based on deep learning and keeps changing based on price fluctuations, volume shifts, and market cycles.

Share Price Targets Last Updated on Jan 25, 2025 at 3:06:09 AM

Morepen Laboratories Share Price Target in the Next 1, 3, 5, 7, and 10 Years

Below you can see Morepen Laboratories long-term share price targets for the next 1, 3, 5, 7, and 10 years

• If we talk about the future stock price target of Morepen Laboratories then it can rise to the minimum price of ₹92.60 and the maximum price of ₹97.22 in the coming 3 years.
• If we estimate the price target for the next 5 years, its value may rise to a minimum price of ₹104.89 and a maximum price of ₹110.88.
• If we forecast the next 7 years its value can increase to a minimum price of ₹115.56 and a maximum price of ₹122.73.
• In the next 10 years, it can increase to a minimum price of ₹134.35 and a maximum price of ₹143.62.

Also Read: Sun Pharma Share Price Target

Morepen Laboratories Share Price Target 2025, 2026, 2027, 2028, 2030, 2032, 2035, 2036

Also Read: Ajanta Pharma Share Price Target

Morepen Laboratories Share Price Target 2025

The current trend of the stock market is likely to remain the same with more or less volatility and the share price of Morepen Laboratories may reach the minimum price of ₹80.54 and the maximum price of ₹83.83.

• The initial share price target for Morepen Laboratories in 2025 is estimated at x.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹78.34 by the mid-year.
• By the end of the year in 2025, Morepen Laboratories share price has the potential to reach ₹83.83.

Also Read: Marksans Pharma Share Price Target

Morepen Laboratories Share Price Target 2026

Based on technical analysis, it is estimated that the minimum target price for Morepen Laboratories stock could be ₹85.49, and the maximum target price is expected to reach ₹89.32 by the end of 2026.

• The initial share price target for Morepen Laboratories in 2026 is estimated at ₹82.40.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹85.12 by the mid-year.
• By the end of the year in 2026, Morepen Laboratories share price has the potential to reach ₹89.32.

Also Read: Apollo Hospitals Share Price Target

Morepen Laboratories Share Price Target 2027

If we estimate the share price target of Morepen Laboratories by the end of 2027, it could reach the minimum price of ₹92.60 and the maximum price of ₹97.22.

• The initial share price target for Morepen Laboratories in 2027 is estimated at ₹89.37.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹92.03 by the mid-year.
• By the end of the year in 2027, Morepen Laboratories share price has the potential to reach ₹97.22.

Also Read: Cipla Share Price Target

Morepen Laboratories Share Price Target 2028

By the end of 2028, the share price of Morepen Laboratories may increase between ₹98.83 to ₹104.15.

• The initial share price target for Morepen Laboratories in 2028 is estimated at ₹95.12.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹98.76 by the mid-year.
• By the end of the year in 2028, Morepen Laboratories share price has the potential to reach ₹104.15.

Also Read: 3M India Share Price Target

Morepen Laboratories Share Price Target 2029

Morepen Laboratories share price may rise to a minimum price of ₹104.89 and a maximum price of ₹110.88 by the end of 2029.

• The initial share price target for Morepen Laboratories in 2029 is estimated at ₹101.33.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹105.05 by the mid-year.
• By the end of the year in 2029, Morepen Laboratories share price has the potential to reach ₹110.88.

Also Read: Abbott India Share Price Target

Morepen Laboratories Share Price Target 2032

By the end of 2032, the share price of Morepen Laboratories may increase to a minimum price of ₹121.84, and a maximum price of ₹129.71.

• The initial price target for Morepen Laboratories in 2032 is estimated at ₹124.47.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹126.20 by the mid-year.
• By September the share price of Morepen Laboratories may touch the level of ₹127.95.
• By the end of the year in 2032, Morepen Laboratories share price has the potential to reach ₹129.71.

Also Read: LIC Share Price Target

Morepen Laboratories Share Price Target 2036

If we look at the long-term growth potential, Morepen Laboratories stock has the potential to reach a minimum price of ₹146.89 and a maximum price of ₹157.54 by the end of 2036.

• The initial price target for Morepen Laboratories in 2036 is estimated at ₹152.30.
• Under favorable market conditions, the share price of Morepen Laboratories may rise to ₹154.04 by the mid-year.
• By September the share price of Morepen Laboratories may touch the level of ₹155.79.
• By the end of the year in 2036, Morepen Laboratories share price has the potential to reach ₹157.54.

Also Read: KIMS Share Price Target

FAQ: Morepen Laboratories Share Price Target

Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. For complete information read the disclaimer page.